Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long-term post-acute sequelae of COVID-19 infection: a retrospective, multi-database cohort study in Hong Kong and the UK
Ivan Chun Hang Lam, Carlos King Ho Wong, Ran Zhang, et al.
EClinicalMedicine (2023) Vol. 60, pp. 102000-102000
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

Persistence in risk and effect of COVID-19 vaccination on long-term health consequences after SARS-CoV-2 infection
Ivan Chun Hang Lam, Ran Zhang, Kenneth K. C. Man, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 24
Association of nirmatrelvir–ritonavir with post-acute sequelae and mortality in patients admitted to hospital with COVID-19: a retrospective cohort study
Huwen Wang, Yuchen Wei, C.T. Hung, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 10, pp. 1130-1140
Open Access | Times Cited: 13
Impact of Pre-Infection COVID-19 Vaccination on the Incidence and Severity of Post-COVID Syndrome: A Systematic Review and Meta-Analysis
Milena Adina Man, Daniela Rosca, Felix Bratosin, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 189-189
Open Access | Times Cited: 11
Long-term risks of respiratory diseases in patients infected with SARS-CoV-2: a longitudinal, population-based cohort study
Meijun Meng, Rui Wei, Yanjun Wu, et al.
EClinicalMedicine (2024) Vol. 69, pp. 102500-102500
Open Access | Times Cited: 11
Differential decline of SARS‐CoV‐2‐specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID‐19
Bernhard Kratzer, Pia Gattinger, Doris Trapin, et al.
Allergy (2024) Vol. 79, Iss. 9, pp. 2482-2501
Open Access | Times Cited: 5
Modifiable lifestyle factors and the risk of post-COVID-19 multisystem sequelae, hospitalization, and death
Yunhe Wang, Binbin Su, Marta Alcalde-Herraiz, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Effectiveness of nirmatrelvir/ritonavir and molnupiravir on post-COVID-19 outcomes among outpatients: a target trial emulation investigation
Yuchen Wei, Christopher Boyer, Katherine Min Jia, et al.
Emerging Microbes & Infections (2025)
Open Access
Demographic, epidemiological and clinical profile of patients with post-COVID syndrome followed at a teaching hospital in Brazil
João Ricardo Herênio de Melo, Alex Eduardo da Silva, Leona Yamamoto, et al.
The Brazilian Journal of Infectious Diseases (2025) Vol. 29, Iss. 2, pp. 104509-104509
Closed Access
Short- and long-term comparative effectiveness of nirmatrelvir/ritonavir and molnupiravir in asthma patients: a cohort study
Guozhang Lin, Yuchen Wei, Zihao Guo, et al.
Respiratory Research (2025) Vol. 26, Iss. 1
Open Access
Long-term health outcomes following hospitalisation for COVID-19: a 30- month cohort analysis
Sarah Tubiana, M. Rontani, Philippe Herlemont, et al.
Infectious Diseases (2025), pp. 1-11
Closed Access
Opportunities and Challenges in Using Electronic Health Record Systems to Study Postacute Sequelae of SARS-CoV-2 Infection: Insights From the NIH RECOVER Initiative
Hannah Mandel, Shruti Shah, L. Charles Bailey, et al.
Journal of Medical Internet Research (2025) Vol. 27, pp. e59217-e59217
Open Access
Psychiatric and neuropsychiatric sequelae of COVID-19 within 2 years: a multinational cohort study
Yi Chai, Ivan Chun Hang Lam, Kenneth K. C. Man, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
Mid- and long-term mortality risk factors after COVID-19 hospitalization: A retrospective observational study in Peru
Max Carlos Ramírez-Soto, Hugo Arroyo-Hernández
Vaccine X (2025), pp. 100631-100631
Open Access
Long-term cardiovascular, cerebrovascular, and thrombotic complications after SARS-CoV-2-Omicron infection: a retrospective cohort study
Liang En Wee, Jue Tao Lim, An Ting Tay, et al.
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 10, pp. 1319-1326
Closed Access | Times Cited: 4
Cardiovascular disease risk after a SARS-CoV-2 infection: A systematic review and meta-analysis
Karla Romero Starke, Pauline Kaboth, Natalie Rath, et al.
Journal of Infection (2024) Vol. 89, Iss. 3, pp. 106215-106215
Open Access | Times Cited: 4
Characterization of long COVID temporal sub-phenotypes by distributed representation learning from electronic health record data: a cohort study
Arianna Dagliati, Zachary H. Strasser, Zahra Shakeri Hossein Abad, et al.
EClinicalMedicine (2023) Vol. 64, pp. 102210-102210
Open Access | Times Cited: 10
The outcomes of COVID-19 and acute pancreatitis: a systematic review and meta-analysis
Caiyu Zhu, Haijuan Wu, Yang Xiangyu, et al.
Translational Gastroenterology and Hepatology (2024) Vol. 9, pp. 6-6
Open Access | Times Cited: 3
Visualization of Early RNA Replication Kinetics of SARS-CoV-2 by Using Single Molecule RNA-FISH Combined with Immunofluorescence
Rajiv Pathak, Carolina Eliscovich, Ignacio Mena, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 262-262
Open Access | Times Cited: 3
Risk of incident atrial fibrillation after COVID-19 infection: A systematic review and meta-analysis
Marco Zuin, Luisa Ojeda‐Fernández, G Torrigiani, et al.
Heart Rhythm (2024) Vol. 21, Iss. 9, pp. 1613-1620
Closed Access | Times Cited: 3
Risks of cutaneous immune‐related adverse events in long COVID: Multinational cohort studies in South Korea, Japan, and the UK
Hye Jun Kim, Seoyeon Kyung, Jaeyu Park, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 6
Closed Access | Times Cited: 3
The potential clinical impact and cost-effectiveness of the updated COVID-19 mRNA autumn 2024 vaccines in the United Kingdom
Michele Kohli, Michael Maschio, Amy Lee, et al.
Journal of Medical Economics (2024) Vol. 27, Iss. 1, pp. 1359-1372
Open Access | Times Cited: 3
The Potential Role of Hypothalamic Phospholipid Liposomes in the Supportive Therapy of Some Manifestations of Post-COVID-19 Condition: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Brain Fog
Francesco Menichetti
Journal of Clinical Medicine (2023) Vol. 12, Iss. 17, pp. 5478-5478
Open Access | Times Cited: 9
Utility of Serum Ferritin for Predicting Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Patients with Long COVID
Yukichika Yamamoto, Yuki Otsuka, Kazuki Tokumasu, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 14, pp. 4737-4737
Open Access | Times Cited: 8
Pulmonary Sequelae of COVID-19: Focus on Interstitial Lung Disease
Janet Johnston, Delia Dorrian, Dermot Linden, et al.
Cells (2023) Vol. 12, Iss. 18, pp. 2238-2238
Open Access | Times Cited: 8
Multi-omics landscapes reveal heterogeneity in long COVID patients characterized with enhanced neutrophil activity
Ke Lin, Jian‐Peng Cai, Jingxin Guo, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top